This invention relates to a dry powder pharmaceutical suspension composition of 6-Mercaptopurine(6-MP) comprising of 6- Mercaptopurine and pharmaceutically acceptable excipients for the treatment for acute lymphoblastic leukaemia (ALL), the present invention isdesigned to provideflexible and accurate dose administra...
The present invention relates to a stable oral liquid pharmaceutical composition of 13-cis retinoic acid or its pharmaceutically accepted salts thereof. The present invention also provides the process of preparation of such compositions.